These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9553457)

  • 21. Compliance with antihypertensive therapy: raising the bar of expectations.
    Rudd P
    Am J Manag Care; 1998 Jul; 4(7):957-66. PubMed ID: 10181995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detecting and improving compliance. Is concordance the solution?
    Yasin S
    Aust Fam Physician; 1998 Apr; 27(4):255-60. PubMed ID: 9581332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Existing treatment strategies: does noncompliance make a difference?
    Caro JJ; Speckman JL
    J Hypertens Suppl; 1998 Sep; 16(7):S31-4. PubMed ID: 9855029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of resistant hypertension].
    Baumgart P
    Med Klin (Munich); 2005 Apr; 100(4):200-6; quiz 207-8. PubMed ID: 15834529
    [No Abstract]   [Full Text] [Related]  

  • 25. Improving patients' compliance with antihypertensive regimens.
    Cohen SJ
    Compr Ther; 1985 Oct; 11(10):18-21. PubMed ID: 4053556
    [No Abstract]   [Full Text] [Related]  

  • 26. [The influence of socio-economic factors on the compliance of patients with treatment of hypertonic disease].
    Serov VA; Gorbunov VI
    Klin Med (Mosk); 2007; 85(3):65-8. PubMed ID: 17523410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Advances in the therapy of hypertension].
    Januszewicz W
    Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():7-8; discussion 8-10. PubMed ID: 12621773
    [No Abstract]   [Full Text] [Related]  

  • 28. Overcoming barriers: the role of providers in improving patient adherence to antihypertensive medications.
    Harmon G; Lefante J; Krousel-Wood M
    Curr Opin Cardiol; 2006 Jul; 21(4):310-5. PubMed ID: 16755199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible side effects should be discussed with patients.
    Adegbile J
    Am Fam Physician; 2003 Mar; 67(6):1188-9. PubMed ID: 12674446
    [No Abstract]   [Full Text] [Related]  

  • 30. Provocative results suggest lower BP targets may be advisable for CAD patients.
    Dis Manag Advis; 2004 Dec; 10(12):142-4, 133. PubMed ID: 15673130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Physician-patient disagreement about medication results in impaired health and risk of recurrence].
    Dencker SJ
    Lakartidningen; 2005 Jan 17-23; 102(3):146-7. PubMed ID: 15712741
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of patient compliance in the treatment of hypertension. Report of the NHLBI Working Group.
    Hypertension; 1982; 4(3):415-23. PubMed ID: 7068197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antihypertensive treatment and compliance. Pharmacological properties of antihypertensive drugs research need to be acknowledged.
    Schroeder K; Montgomery A; Ebrahim S
    BMJ; 2001 Nov; 323(7321):1129-30. PubMed ID: 11725757
    [No Abstract]   [Full Text] [Related]  

  • 34. Taking antihypertensive medication--controlling or co-operating with patients?
    Kjellgren KI; Ahlner J; Säljö R
    Int J Cardiol; 1995 Jan; 47(3):257-68. PubMed ID: 7721502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toward better control of hypertension: targeting patient compliance.
    Golden W; Potts SG; West DS; Kinggard T;
    J Ark Med Soc; 2007 Aug; 104(2):36-7. PubMed ID: 17902602
    [No Abstract]   [Full Text] [Related]  

  • 36. Obtaining optimal compliance with drug therapy.
    Cramer JA
    Manag Care; 2003 Oct; 12(10 Suppl):9-11; discussion 23-5. PubMed ID: 14606251
    [No Abstract]   [Full Text] [Related]  

  • 37. Reasons for non-compliance with antihypertensive medication in southwest Nigeria.
    Alebiosu CO; Raimi TH; Ayodele OE; Bassi PU; Salako BL; Olutoyin AA; Abbas BA
    Trop Doct; 2004 Apr; 34(2):127-8. PubMed ID: 15117162
    [No Abstract]   [Full Text] [Related]  

  • 38. [Is patient education a factor elevating efficacy of arterial hypertension control?].
    Kobalava ZhD; Villeval'de SV
    Kardiologiia; 2007; 47(10):75-82. PubMed ID: 18260951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unaffordable drug prices: the major cause of non-compliance with hypertension medication in Ghana.
    Ohene Buabeng K; Matowe L; Plange-Rhule J
    J Pharm Pharm Sci; 2004 Nov; 7(3):350-2. PubMed ID: 15576016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Validity of four indirect methods which evaluate therapeutic compliance for arterial hypertension].
    Gil VF; Belda J; Muñoz C; Martínez JL; Soriano JE; Merino J
    Rev Clin Esp; 1993 Nov; 193(7):363-7. PubMed ID: 8290755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.